Stocktoria
Rein Therapeutics, Inc. RNTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2017-06-29
Rein Therapeutics, Inc. statistics & valuation
Market cap$83.1M
P / B4.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -206.4% | -101.1% | -14.8% | -124.2% | -54.0% |
| Return on equity | -294.8% | -115.6% | -16.0% | -146.7% | -59.6% |
| Current ratio | 0.70 | 2.38 | 4.17 | 6.46 | 10.69 |
Source: SEC EDGAR filings · CIK 0001420565 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.